RBC Capital Downgrades Moonlake Immunotherapeutics (MLTX) to Sector Perform Sep 29, 2025 12:49AM
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone' Sep 11, 2025 08:18AM
RBC Capital: 'Moonlake Immunotherapeutics (MLTX) Remains A Top Catalyst-Driven Idea' Jun 3, 2025 09:31AM
Biotech sector Q1 earnings preview from RBC Capital Markets Apr 12, 2025 04:00AM